Madrona Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.8M Sell
131,913
-4,542
-3% -$717K 3.22% 7
2026
Q2
$21.6M Buy
136,455
+4,417
+3% +$597K 3.98% 7
2026
Q1
$16.9M Buy
132,038
+5,087
+4% +$635K 3.69% 7
2025
Q4
$15.5M Sell
126,951
-1,572
-1% -$180K 3.31% 9
2025
Q3
$12.9M Buy
128,523
+2,830
+2% +$255K 2.84% 9
2025
Q2
$10.4M Buy
+125,693
New +$10M 2.5% 13
2022
Q2
– Sell
-3,806
Closed -$352K – 85
2022
Q1
$352K Sell
3,806
-18,612
-83% -$1.72M 0.17% 57
2021
Q4
$2.51M Buy
22,418
+1,453
+7% +$175K 1.06% 25
2021
Q3
$2.64M Buy
20,965
+1,082
+5% +$139K 1.25% 21
2021
Q2
$2.69M Buy
19,883
+426
+2% +$56K 1.38% 20
2021
Q1
$2.64M Buy
19,457
+1,288
+7% +$193K 1.35% 22
2020
Q4
$2.56M Buy
18,169
+480
+3% +$61.5K 1.43% 20
2020
Q3
$1.97M Buy
+17,689
New +$1.98M 1.24% 21

Other funds holding XBI

Madrona Financial Services's XBI Position: Q3 2026 in Review

Madrona Financial Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3.3% in Q3 2026, selling an estimated $717K and leaving 131,913 shares worth $20.8M. The position accounts for 3.22% of the portfolio, ranked #7.

Madrona Financial Services first reported a position in XBI in Q3 2020 and has held it in 13 quarters since. The position peaked at $21.6M in Q2 2026. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Madrona Financial Services held 131,913 shares of State Street SPDR S&P Biotech ETF worth $20.8M as of Q3 2026.
  • Madrona Financial Services sold 4,542 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $717K.
  • State Street SPDR S&P Biotech ETF made up 3.22% of Madrona Financial Services's portfolio in Q3 2026, its #7 holding.
  • Madrona Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 13 quarters since.
  • Madrona Financial Services's State Street SPDR S&P Biotech ETF position peaked at $21.6M in Q2 2026.
  • 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Madrona Financial Services's 13F filing for Q3 2026, filed 23 Oct 2026.